The expanded polyglutamine (polyQ) tract form of ataxin-1 drives disease progression in spinocerebellar ataxia type 1 (SCA1). Although polyQ-ataxin-1 is known to form distinctive intranuclear bodies, the cellular pathways and functions it influences remain poorly understood. Here, we identify direct and proximal partners constituting the interactome of ataxin-1[85Q] in Neuro-2a cells. Pathways analyses indicate a significant enrichment of essential nuclear transporters in the interactome, pointing to disruptions in nuclear transport processes in the presence of polyQ-ataxin-1. Our direct assessments of nuclear transporters and their cargoes reinforce these observations, revealing disrupted trafficking often with relocalisation of transporters and/or cargoes to ataxin-1[85Q] nuclear bodies. Strikingly, the nucleoporin Nup98, dependent on its GLFG repeats, is recruited into polyQ-ataxin-1 nuclear bodies. Our results highlight a disruption of multiple essential nuclear protein trafficking pathways by polyQataxin-1, a key contribution to furthering understanding of pathogenic mechanisms initiated by polyQ tract proteins.
Introduction
Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant neurodegenerative disease, associated with disabilities in coordination and movement and a marked atrophy in the cerebellum and brainstem 1 . The genetic cause underlying SCA1 has been mapped to ATXN1, the gene encoding the ataxin-1 protein, whereby the CAG nucleotide repeat region of ATXN1 is expanded in SCA1 patients 2 . The resulting polyglutamine (polyQ) tract form of the ataxin-1 protein, polyQ-ataxin-1, forms distinctive nuclear bodies in individuals with SCA1, a feature recapitulated in SCA1 transgenic mice 3 . More broadly, polyQ tract expansions in specific proteins are now appreciated to drive at least 10 diseases 4 , and their study is providing exciting new insights that extend beyond critical aspects of protein biochemistry including protein folding/misfolding and protein-protein interactions to important points of regulation in cellular homeostasis dictated by proteostasis and impacts on cell survival/death-decision making 5, 6, 7, 8, 9, 10, 11, 12 .
Several studies have reported disruptions in nuclear import/export processes in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and Huntington's disease (HD) 13, 14, 15, 16 . The nuclear transport machinery responsible for the regulated trafficking of proteins between the cytoplasm and the nucleus has a number of key components:
nuclear import/export signals (NLS/NES) of the cargo proteins that direct their nuclear/cytoplasmic distributions, dedicated transport proteins responsible for nuclear import (importins) and export (exportins), the nuclear pore complex that spans the nuclear envelope and provides a regulated gateway for nuclear trafficking events, and the RanGTP/RanGDP system that drives directionality of the transport events 17, 18 . Disrupting any of these entities can influence nucleocytoplasmic trafficking 19, 20, 21 , making each of these a potential player in altered nuclear trafficking in neurodegenerative disease.
Here we approach the issues of the actions of polyQ-ataxin-1 from the perspective of proteininteraction networks, by first defining the interactome of ataxin-1 [85Q] . By combining direct interaction analyses with our identification of polyQ-ataxin-1 proximal partners and pathways analyses, we not only confirm several known ataxin-1 interacting partners but we identify the nuclear transport pathway as the top-ranked cellular process defined by these interactors. By sequestering additional proteins into ataxin-1 nuclear bodies, polyQ-ataxin-1 has the potential to disrupt cellular homeostasis 22, 23, 24 . To assess this possibility of ataxin-1 driven nuclear transport disruption, we define the relocalisation of multiple components of the nuclear transport machinery, often with their redistribution to ataxin-1[85Q] nuclear bodies. Our results reinforce a direct sequestration model for the impact of polyQ-ataxin-1 nuclear bodies.
Results and Discussion

Ataxin-1[85Q] forms distinctive nuclear bodies that are enhanced by arsenite stress
To define the suitability of the polyQ-ataxin-1 constructs GFP-ataxin-1[85Q] and MBI-ataxin-1[85Q] for interactome analyses in Neuro-2a cells, we assessed the subcellular localization of these proteins, compared to GFP or MBI alone, under control conditions and further in response to the pro-oxidant stressor arsenite 25, 26 . Whilst GFP remains broadly distributed throughout the cell, GFP-ataxin-1[85Q] forms distinctive nuclear bodies that have been reported across a range of cell types 22, 27, 28 ; these GFP-ataxin-1[85Q] nuclear bodies formed within 24 h of transfection and increased in size upon acute arsenite exposure (300 µM, 1 h) further highlighting their responsiveness to altered environmental conditions ( Figure 1A ).
Proximity biotinylation as driven by BirA* biotin ligase provides an alternative proteomics strategy for proximal partner identification 29 . MBI-ataxin-1[85Q], the myc-tagged BirA* N-terminal fusion with ataxin-1[85Q], was thus validated as per our workflow ( Figure 1B ). In contrast to MBI alone that was primarily cytoplasmic, MBI-ataxin-1[85Q] was largely restricted to the nucleus ( Figure 1C ). Streptavidin-based detection further confirmed widespread biotinylation by MBI alone whereas MBI-ataxin-1[85Q]-driven biotinylation was largely localised to prominent nuclear bodies ( Figure 1C ) with a restricted biotinylation profile as defined by streptavidin-detection of biotinylated proteins separated by SDS-PAGE ( Figure   1D ). Thus, we confirmed the formation of distinctive nuclear bodies by GFP-ataxin-1[85Q] or MBI-ataxin-1[85Q] and the suitability of these proteins for more detailed analyses of the polyQ-ataxin-1 interactome.
Complementary proteomics approaches identify nuclear transport proteins in the polyQ-
ataxin-1 interactome
In subsequent analyses, we combined the power of BioID and Pulldown protocols as alternative Following trypsin-digestion of the proteins captured in the two different isolation protocols, our mass spectrometry and peptide raw data analysis defined the proteins present in each individual sample ( Figure 2B ). From the samples analysed as biological triplicates across the 4 conditions (BioID + arsenite, Pulldown + arsenite), and with the removal of non-specific proteins identified (see Methods), we recorded a total of 675 proteins (Supplementary Table   S1 ), extending the breadth of the interactome of polyQ-ataxin-1, as previously investigated in non-neuronal (HEK293T) cell lysates co-immunoprecipitated with myc-ataxin-1 31 . Of note, we identified ataxin-1 itself, as well the well-characterised ataxin-1 partner protein Capicua transcriptional repressor (CIC) 5, 32, 33, 34 under all 4 conditions, supporting the robustness of our approaches.
Of the 675 proteins of the ataxin-1 interactome, 91 were observed in at least 3 out of 4 of the conditions analysed ( Figure 2B & C), Ingenuity Pathway Analysis revealing the top-ranked pathway to be Ran signaling ( Figure 2D ; see summary in Supplementary Table S2 ). Previous studies have reported the ALS-causing C9orf72 repeat expansion RNA product to interact directly with the Ran regulator Ran GTPase activating protein 1 (RanGAP1), resulting in its mislocalization and disruption of nucleocytoplasmic transport 14 . Significantly, RanGAP1, as well as the NPC component nucleoporin NUP62, colocalize with huntingtin protein aggregates processes.
Classical nuclear transport pathways are disrupted by polyQ-ataxin-1
To begin to define the impact of polyQ-ataxin-1 on nuclear transport, we first examined wellcharacterised members of the importin (IMP) superfamily of nuclear transporters, importin-α2 (IMPα2), importin-β1 (IMPβ1) and exportin-1 (also known as CRM1 on nucleocytoplasmic distribution under either control or arsenite stress conditions ( Figure 3 ).
In the presence or absence of arsenite, GFP-IMPα2 was primarily nuclear, as previously denoted by arrows). This was confirmed by image analysis to determine the nuclear to cytoplasmic ratio (Fn/c) ( Figure 4B ).
Other nuclear import pathways are selectively influenced by polyQ-ataxin-1
To extend our survey of nuclear transporters in the presence of polyQ-ataxin-1 expression at the single cell level, we next evaluated additional nuclear transport proteins. Comparable to our initial findings (Figure 3 ), we observed mislocalisation of both importin-13 (IMP13) 39 ( Fig   5A) , and Hikeshi, a non-importin that is responsible for nuclear import of heat shock protein 70 (HSP70) in response to heat shock 40 ( Fig 5B) . Both GFP-IMP13 and -Hikeshi were primarily nuclear in the prescence or absence of arsenite stress, but showed partial co- Table S1 ), the implication is that significant mislocalization of RanGAP1 requires longer term exposure to polyQ-ataxin-1 aggregates, as observed for huntingtin-RanGAP1 association in vivo 15 . In contrast, our assessment of endogenous RCC1 or ectopically addressed GFP-RCC1 revealed clear colocalisation with polyQ-ataxin-1 nuclear bodies ( Figure S3A ,B). Thus, through sequestrating RCC1 into distinct nuclear bodies, polyQ-ataxin-1 has the potential to reduce nuclear RanGTP levels, and hence importin/exportin-dependent nuclear trafficking.
Additionally, not all RCC1 is sequestered into polyQ-ataxin-1 nuclear bodies, explaining how there is not complete disruption of the localization of all nuclear transporters/nuclear transport pathways. Furthermore, that Ran-independent (Hikeshi) and Ran-dependent (importins/exportins) nuclear transport pathways are impacted by polyQ-ataxin-1 expression suggests that there may be additional effects at the level of the nuclear pore complex (NPC).
PolyQ-ataxin-1 expression results in mislocalisation of nucleoporin NUP98
The NPC is the regulated gateway for trafficking between the cell cytosol and nucleus, and is a potential target of mutant polyQ-huntingtin protein in HD 16 , where progressive disruption of nuclear envelope morphology has been observed in aging mice expressing the polyQhuntingtin protein 15 . Post-mortem samples from patients with ALS 42 also show disruptions to the nuclear envelope, whereas polyQ-ataxin-1 may also decrease nuclear membrane instability 43 .
We set out to evaluate the effect of short-term expression of polyQ-ataxin-1, initially by assessing NPC distribution using the anti-nucleoporin (Nup) Mab414 antibody; no marked changes in staining were observed upon polyQ-ataxin-1 expression ( Figure 6A ) indicating no wide-spread disruption of NPC distribution in the nuclear envelope. Indicative of general NPC functionality, nuclear accumulation of the transcription factor AF10, known to be importin/Ran-independent and to occur via direct interaction with NPC components 44, 45 was not affected by polyQ-ataxin-1 ( Figure S4 ). Nucleoporin protein NUP62, within the central core of the NPC 46, 47 , was not altered in the presence of polyQ-ataxin-1 either in the presence or absence of arsenite stress ( Figure S5 ), in contrast to the impact of mutant huntingtin in HD 16 . Importantly, although NUP62 staining showed distinctive nuclear puncta, these did not colocalise with the polyQ-ataxin-1 nuclear bodies ( Figure S5 ), indicating that the effects of polyQ-ataxin-1 and mutant huntingtin are distinct, although both impact nuclear transport machinery.
We next evaluated NUP98, the most conserved FG-dipeptide motif domain nucleoporin and a major contributor to the NPC permeability barrier 48, 49 . Indeed, the more cohesive nature of NUP98 GLFG repeat domains compared to the FxFG repeats of other nucleoporins 50 can drive the formation of highly concentrated gels 51 . Immunostaining of endogenous NUP98 revealed its distribution throughout the cell with recruitment into polyQ-ataxin-1 nuclear bodies ( Figure   6B , denoted by white arrowheads in Zoom panels). Analogously, ectopically expressed GFP-NUP98, colocalised with polyQ-ataxin-1 nuclear bodies upon arsenite exposure ( Figure 7A ).
To further dissect the mechanisms contributing to this co-localisation, we evaluated the localisation patterns of three truncation derivatives of NUP98: GFP-NUP98 N-terminal (1-225), GFP-NUP98 GLFG domain (221-504) and GFP-NUP98 C-terminal (506-920). We observed overlap but no enrichment in fluorescence colocalised with the polyQ-ataxin-1 nuclear bodies for the N-terminal or C-terminal constructs ( Figure 7B ). In contrast, we observed small nuclear puncta for GFP-NUP98 GLFG domain (221-504) even in the absence of polyQ-ataxin-1 ( Figure 7B , denoted by open arrowheads in Zoom panels); upon arsenite treatment, striking colocalisation in the larger polyQ-ataxin-1 nuclear bodies was also evident ( Figure 7B , denoted by white arrowheads in Zoom panels). Thus, sequestration of NUP98 into the polyQ-ataxin-1 nuclear bodies is dependent on the NUP98 GLFG domain.
Previous studies using knockdown of NUP98 to interrogate its functions have shown selective disruption of Tag-NLS-/importin α/β1-dependent and M9-NLS-/transportin-1 (TNPO1)-dependent nuclear protein import, but not BIB ("β-importin-binding")-NLS-dependent transport, that can be mediated by multiple different importin βs! 20, 52 . To test the possible impact of NUP98 sequestration by polyQ-ataxin-1 nuclear bodies on nuclear transport, we examined the subcellular localisation of GFP-M9-NLS and GFP-BIB-NLS. We found that the extent of nuclear accumulation of GFP-M9-NLS, but not of GFP-BIB-NLS was significantly (p < 0.05) increased in the presence of polyQ-ataxin-1 expression and arsenite induced stress ( Figure S6 ). These results further support the observations that some, but not all, nuclear transport processes are disrupted by polyQ-ataxin-1.
The ataxin-1 interactome indicates impacts on multiple intracellular processes beyond nuclear transport
Previous genetic screens have highlighted the impact of nuclear transport proteins across a number of neurodegenerative diseases. In exploring suppressors of C9orf72 repeat expansion toxicity in Drosophila ALS model, multiple nuclear pore complex proteins, importins/exportins and Ran regulators have been identified 13, 14, 53 . The earlier screens for genetic suppressors of ataxin-1-induced neuronal degeneration in a Drosophila SCA1 model previously identified the nucleoporin NUP44A as a suppressor of toxicity 54, 55 . Our study is the first to investigate the impact of short-term polyQ-ataxin-1 expression on cellular nuclear transport processes, our findings indicating that nuclear transport is directly disrupted by shortterm polyQ-ataxin-1 expression. Our proteomics analyses, in combination with our surveying of additional nuclear transporters, Ran regulators and nucleoporins, point to the disruption at multiple critical points across the cellular nuclear transport system.
Our results emphasize that approaches to rescue the nuclear transport disruption by mutant ataxin-1 may ultimately provide new ideas on the possible therapeutic interventions to slow neurodegenerative disease progression in SCA1. Furthermore, the ataxin-1 interactome remains a resource for further exploration. For example, we identified replication protein A1
(Rpa1) by pulldown approaches (Table S1 ); Rpa1 has been previously identified as having the largest effect on lifespan in the Drosophila SCA1 model and has been located at the hub position linked to repair systems such as homologous recombination 56 . Others have implicated genes in the protein folding/heat-shock response or ubiquitin-proteolytic pathways as modifiers of toxicity in models of SCA1 54 and our proteomics studies have identified multiple heat shock proteins as well as proteins involved in ubiquitination, and ubiquitin itself, as part of the ataxin-1 interactome (Table S1 ). Ataxin-1 phosphorylation may also influence ataxin-1 stability 57 ;
with the implication of cAMP-dependent protein kinase as a mediator of phosphorylation and toxicity of ataxin-1 58, 59 , it is of interest that we identified both regulatory and catalytic subunits of cAMP-dependent protein kinase in our interactome analysis (Supplementary Table S1 ).
Increasing levels of wild-type ataxin-1 are sufficient to lead to SCA1-like neurodegeneration 60 , and thus the exact balance of binding partner selection by ataxin-1 is of critical importance.
Deciphering the cellular events underlying the ataxin-1 interactome may well be the key to new treatment options for SCA1 and other neurodegenerative diseases.
Materials and methods
Plasmids
The (for blot detection or proteomics protocols).
Cell lysate preparation and pull-down protocols
Cell lysates were prepared using RIPA buffer [50 mM Tris-HCl, pH 7.3, 150 mM NaCl, 0.1 mM ethylenediaminetetraacetic acid (EDTA), 1% sodium deoxycholate, 1% Triton X-100, 0.2% NaF and 100 µM Na 3 VO 4 ] supplemented with complete protease inhibitor mix (Roche Diagnostic). Cell lysates were incubated on ice (20 min) and cleared by centrifugation (1,000 rpm, 20 min). Protein concentrations were determined using the BioRad assay.
For BioID pull-down prior to mass spectrometry or immunoblot analysis, whole cell lysates (3 mg protein) prepared from Neuro-2a cells expressing MBI-ataxin-1[85Q] were incubated with streptavidin-agarose (0.05 mL) (Invitrogen). For GFP pull-down prior to mass spectrometry or immunoblot analysis, whole cell lysates prepared from Neuro-2a cells expressing GFP fusion constructs (3 mg protein) were incubated with GFP-trap-agarose (0.05 mL) (ChromoTek). The incubation for streptavidin-agarose was overnight at 4ºC, and for GFP-trap-agarose was 2 h at room temperature. The immobilized proteins in the streptavidin-or GFP-trap-agarose pellets were thoroughly washed. For both protocols, 7 wash steps were performed, with centrifugation (12,000 rpm, 1 min) between washes and with the first 2 washes using RIPA buffer. For the BioID pull-down, the 5 subsequent wash steps included: 0.5% SDS in PBS (washes 3 and 4), 6 M urea in 100 mM TrisHCl pH 8.5 (washes 5 and 6), and 100 mM TrisHCl pH 8.5 (wash 7).
For the GFP pull-down, all 5 subsequent washes used 10 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5 mM EDTA (washes 3 to 7).
Blot detection of biotinylated proteins
Proteins binding to the streptavidin-agarose were eluted with concentrated SDS-sample buffer (180 mM TrisHCl pH 6.8, 30% glycerol, 6% SDS, 0.06% bromophenol blue, 15% β-mercaptoethanol). Samples were boiled (5 min, 95ºC). Eluted proteins were separated by SDS-PAGE (8% polyacrylamide gels, 1. The membrane was finally blocked with buffer (1% BSA, 1% Triton X-100 in PBS; 5 min), washed (TBST, 3 x 1 min), and visualised using an enhanced chemiluminescence detection system (ThermoFisher Scientific). Images were captured using ChemiDoc imager (Bio-Rad) operating in a single-channel protocol.
Mass spectrometry (MS) analysis
Proteins in the washed streptavidin-or GFP-trap-agarose pellets were further prepared for MS analysis. For streptavidin-agarose pellets, an on-bead digestion was performed by adding 20 µl 
Statistical analysis
Graphpad Prism 6 (version 6.00 for Mac) was used for statistical analysis. For analysis of >2 datasets, ANOVA was applied to compare differences among different datasets, followed by 
